By Amir Amini
Clinical
October 12, 2017

CNN Investigates: The little red pill being pushed on the elderly

The maker of a little red pill intended to treat a rare condition is raking in hundreds of millions of dollars a year as it aggressively targets frail and elderly nursing home residents for whom the drug may be unnecessary or even unsafe, a CNN investigation has found.

Nuedexta is approved by the Food and Drug Administration (FDA) to treat anyone with PBA, including those with a variety of neurological conditions such as dementia. But geriatric physicians, dementia researchers and other medical experts told CNN that PBA is extremely rare in dementia patients; several said it affects 5% or less. And state regulators have found doctors inappropriately diagnosing nursing home residents with PBA to justify using Nuedexta to treat patients whose confusion, agitation and unruly behavior make them difficult to manage.

Please read below link. 

http://www.cnn.com/2017/10/12/health/nuedexta-nursing-homes-invs/index.html

Author Description

Amir Amini

Amir is a Pharmacist Consultant at SCRx Pharmacy. He has years of experience working with the major SNF providers in Southern Ca.

Stay Informed

Sign up to receive the latest news about SCRx services, the industry and more.

Contact Us

Call us with your questions
619.785.3993